SS
Steve Seedhouse Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
26
Avg Return
Past Year
Past Year
16%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
72.7%
Neutral
27.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Asset Management
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Assumed
| $154 |
2%
upside
| 1 | +26% |
0
%
| 24 Nov ‘25 10 days ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | +44% |
0
%
| 13 Nov ‘25 21 days ago |
|
|
|
Neutral
Downgraded
| – | – | 2 | +59% |
0
%
| 12 Nov ‘25 22 days ago |
|
|
|
Overweight
Maintained
| $42 |
133%
upside
| 2 | +24% |
0
%
| 6 Nov ‘25 28 days ago |
|
|
|
Overweight
Maintained
| $31 |
49%
upside
| 1 | +4.8% |
0
%
| 6 Nov ‘25 28 days ago |
|
|
|
Overweight
Maintained
| $26 |
231%
upside
| 1 | -0.2% |
0
%
| 15 Oct ‘25 1 month ago |
|
|
|
Overweight
Initiated
| $7 |
105%
upside
| 1 | +16% |
0
%
| 2 Oct ‘25 2 months ago |
|
|
|
Market Perform
Downgraded
| – | – | 1 | +50% |
–
| 19 Sep ‘25 2 months ago |
|
|
|
Outperform
Reiterated
| $63 |
40%
upside
| 1 | +41% |
0
%
| 9 Sep ‘25 2 months ago |
|